Study links AstraZeneca's Covid vaccine to higher risk of very rare clot

Several countries have already altered their advice after previous research indicated that, in rare number of cases, thrombosis with thrombocytopenia syndrome (TTS) can be a possible side effect of Covid vaccines that use an adenovirus vector, or "engineered" virus, such as those from AstraZeneca and Johnson & Johnson.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nBYq7eU
via IFTTT